| 
|  | MBX2982Description of:MBX2982MBX-2982 is a potential first-in-class treatment for diabetes that targets G protein-coupled receptor 119 (GPR119), a re...
 More>> |  | 
| 
|  | FadrozoleTheoretical analysis:FadrozoleCBNumber: CB3271421
 Chemical Name: FADROZOLE
 Molecular Formula: C14H13N3
 Formula Weight:...
 More>> |  | 
| 
|  | TOK-001(Galeterone)Description of:TOK-001TOK-001 (VN/124-1; Galeterone; VN 124) is useful for castration resistant prostate cancer (CRPC).
 Theoretical a...
 More>> |  | 
| 
|  | MDV3100(Enzalutamide)Description of:MDV3100(Enzalutamide)MDV3100 has approximately fivefold higher binding affinity for the androgen receptor (AR) compared to the ...
 More>> |  | 
| 
|  | TAK875Description of:TAK875TAK-875 was eliminated slowly with a mean terminal elimination tfrac12 of approximately 28.1 to 36.6 hours. Systemic expo...
 More>> |  | 
| 
|  | GSK1292263Description of:GSK1292263GSK1292263 is a novel GPR119 receptor agonist used for the treatment of type 2 diabetes.
 Theoretical...
 More>> |  | 
| 
|  | AndarineDescription of:AndarineAndarine is an orally active partial agonist for androgen receptors. It is less potent in both anabolic and androgenic ...
 More>> |  |